1. Home
  2. IFF vs ASND Comparison

IFF vs ASND Comparison

Compare IFF & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Flavors & Fragrances Inc.

IFF

International Flavors & Fragrances Inc.

HOLD

Current Price

$70.50

Market Cap

18.1B

Sector

Industrials

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$221.85

Market Cap

14.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFF
ASND
Founded
1833
2006
Country
United States
Denmark
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1B
14.7B
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
IFF
ASND
Price
$70.50
$221.85
Analyst Decision
Buy
Strong Buy
Analyst Count
12
16
Target Price
$89.09
$281.50
AVG Volume (30 Days)
1.2M
751.0K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
2.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$96.35
Revenue Next Year
$3.11
$44.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.14
$151.11
52 Week High
$84.45
$250.74

Technical Indicators

Market Signals
Indicator
IFF
ASND
Relative Strength Index (RSI) 46.44 43.01
Support Level $68.35 $214.92
Resistance Level $75.07 $233.88
Average True Range (ATR) 1.84 7.56
MACD -0.20 -2.06
Stochastic Oscillator 25.64 16.98

Price Performance

Historical Comparison
IFF
ASND

About IFF International Flavors & Fragrances Inc.

International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrances producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients, though IFF plans to divest this business in the future.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: